Actor’s viral post highlights growing celebrity trend of advanced blood filtration, but experts question evidence and high costs.
Peter Facinelli, the actor best known for playing vampire doctor Carlisle Cullen in the Twilight film series, recently shared a video of himself undergoing a high-tech blood purification therapy, humorously tagging it #vampireblood. The treatment, known as EBOO (Extracorporeal Blood Oxygenation and Ozonation), is gaining traction in celebrity wellness circles, with Facinelli stating it “filters and oxygenates your blood with medical-grade ozone to detoxify the body, boost immunity, and reduce inflammation.”
A post shared by EBOO Medical – A Passion For Wellness! (@eboo.medical)
The video, shared with his nearly 1 million followers, shows the actor at a wellness clinic, connected to a machine that processes his blood. EBOO therapy, which typically costs between $2,000 and $5,000 per session, involves drawing blood, separating the plasma, treating it with an ozone-oxygen mixture, and reinfusing it. Proponents, including a growing number of integrative clinics worldwide, claim it removes microplastics, environmental toxins, and inflammatory markers, leading to improved energy, mental clarity, and immune function.
“People are looking for definitive ways to deal with the constant toxic burden of modern life,” said Dr. Anya Petrova, Medical Director of The Longevity Center in Beverly Hills, which offers EBOO. “This isn’t a juice cleanse. It’s a direct, mechanical intervention that can significantly reduce the inflammatory load we know is linked to chronic disease.”
Expert Skepticism and Questions of Evidence
Despite celebrity endorsement and patient testimonials, the medical establishment urges caution. Critics argue that while the procedure’s ability to filter plasma is mechanically sound, conclusive clinical evidence proving its long-term health benefits for the general population is lacking.
“I am aware of the procedure, but I am not aware of rigorous, peer-reviewed studies that demonstrate its proclaimed detoxification benefits translate into measurable health outcomes like reduced disease incidence or increased lifespan,” said Dr. Simon Clarke, an immunologist and professor of cellular microbiology at the University of Reading. “The human body, particularly the liver and kidneys, is exceptionally well-equipped for detoxification. The question isn’t just can it remove certain particles from blood ex vivo, but does doing so provide a clinical advantage that justifies the cost and any associated risks?”
The primary risks, though considered low when performed by trained professionals, include those common to any extracorporeal procedure: infection, vein irritation, and a theoretical risk of air embolism. More broadly, skeptics worry about the “detox” branding.
“The term ‘detox’ is a major red flag in medicine. It’s a marketing term, not a medical one,” noted Dr. Sarah Jenkins, an NHS consultant in general medicine. “There is a concerning lack of regulation around claims made by many clinics offering these expensive, cash-pay procedures. Patients should be extremely wary of any treatment promising to remove so-called ‘toxins’ without clear, independently verified data on what is actually being removed and how that improves health.”
The “Vampire Blood” Allure and the Market for High-End Biohacking
Facinelli’s post taps into a potent mix of sci-fi imagery and cutting-edge science, making advanced therapy accessible through a familiar metaphor. His involvement underscores a burgeoning market where Hollywood’s wellness culture intersects with Silicon Valley’s biohacking ethos, all willing to invest significantly in perceived technological edges for health optimization.
However, this investment is substantial and, like Orlando Bloom’s similar £10,000 treatment, sits firmly outside insurance coverage. This places it firmly in the realm of luxury health, accessible only to a wealthy few.
“The preparation of this treatment relied on patient testimonial and preliminary biochemical studies,” continued Dr. Clarke. “What’s needed now are large-scale, controlled clinical trials. Until then, it should be approached not as established medicine, but as an experimental procedure with unknown long-term value.”
As Peter Facinelli’s video continues to circulate, it fuels a crucial debate: Is EBOO a visionary step towards proactive, personalized medicine, or an expensive example of science being outpaced by sophisticated marketing and the timeless allure of a modern fountain of youth?
The preparation of this article included analysis of public statements, clinical websites, and current scientific commentary on extracorporeal ozone and blood filtration therapies.
